ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACHV Achieve Life Sciences Inc

4.70
0.125 (2.73%)
After Hours
Last Updated: 15:52:38
Delayed by 15 minutes

Period:

Draw Mode:

Volume 57,002
Bid Price 4.55
Ask Price 4.75
News -
Day High 4.64

Low
3.03

52 Week Range

High
10.30

Day Low 4.48
Share Name Share Symbol Market Stock Type
Achieve Life Sciences Inc ACHV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.125 2.73% 4.70 15:52:38
Open Price Low Price High Price Close Price Previous Close
4.57 4.48 4.64 4.61 4.575
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,245 57,002 US$ 4.60 US$ 262,492 - 3.03 - 10.30
Last Trade Type Quantity Price Currency
16:42:15 75 US$ 4.77 USD

Achieve Life Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
97.36M 21.17M - 0 -29.82M -1.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Achieve Life Sciences News

Date Time Source News Article
4/25/202407:00GlobeNewswire Inc.Achieve Life Sciences to Announce First Quarter Financial..
4/11/202407:00GlobeNewswire Inc.Achieve Life Sciences to Present at Life Science Innovation..
3/28/202415:01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Fourth..
3/20/202407:00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA..
3/14/202407:00GlobeNewswire Inc.Achieve Life Sciences to Announce Fourth Quarter and..
3/06/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:41Edgar (US Regulatory)Form 8-K - Current report
2/29/202415:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202407:01GlobeNewswire Inc.Achieve Life Sciences Reaches Agreement with the FDA on..
2/29/202407:00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of up to $124.2..
2/27/202414:32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACHV Message Board. Create One! See More Posts on ACHV Message Board See More Message Board Posts

Historical ACHV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.554.664.354.4951,3680.153.30%
1 Month4.644.69934.024.4866,3990.061.29%
3 Months4.915.003.824.4397,912-0.21-4.28%
6 Months3.995.983.034.1890,2310.7117.79%
1 Year7.9310.303.035.2194,009-3.23-40.73%
3 Years10.9711.752.006.2998,614-6.27-57.16%
5 Years4.0023.240.2257442.11523,0700.7017.50%

Achieve Life Sciences Description

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

Your Recent History

Delayed Upgrade Clock